Healthcare Sector Stocks
The Healthcare sector has a total of 1055 stocks, with a combined market cap of $8.86 trillion, total revenue of $4.58 trillion and a weighted average PE ratio of 44.52.
Market Cap
8.86T
Revenue
4.58T
Profits
199.05B
PE Ratio
44.52
Profit Margin
4.34%
Dividend Yield
0.39%
1055 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | LLY | Eli Lilly and Company | 1.03T | -2.48% | 2,643,042 | 72.25B |
| 2 | JNJ | Johnson & Johnson | 611.07B | -1.52% | 8,770,553 | 96.36B |
| 3 | ABBV | AbbVie Inc. | 432.48B | -1.30% | 5,246,993 | 62.82B |
| 4 | UNH | UnitedHealth Group Incorporated | 386.13B | -0.91% | 5,155,856 | 449.71B |
| 5 | MRK | Merck & Co., Inc. | 298.31B | -2.62% | 9,932,747 | 65.77B |
| 6 | NVS | Novartis AG | 277.39B | -1.96% | 1,239,872 | 56.58B |
| 7 | AZN | AstraZeneca PLC | 256.94B | -2.93% | 3,605,222 | 60.44B |
| 8 | NVO | Novo Nordisk A/S | 216.56B | -0.43% | 6,623,656 | 50.57B |
| 9 | TMO | Thermo Fisher Scientific Inc. | 198.47B | 1.05% | 2,122,396 | 45.20B |
| 10 | AMGN | Amgen Inc. | 191.73B | -1.44% | 1,849,594 | 37.22B |
| 11 | GILD | Gilead Sciences, Inc. | 161.45B | -1.04% | 5,197,828 | 29.74B |
| 12 | ABT | Abbott Laboratories | 154.95B | -3.42% | 12,473,875 | 45.13B |
| 13 | DHR | Danaher Corporation | 140.88B | -0.55% | 4,188,475 | 24.78B |
| 14 | PFE | Pfizer Inc. | 138.21B | -0.94% | 40,863,220 | 63.32B |
| 15 | CVS | CVS Health Corporation | 135.48B | 0.26% | 11,396,138 | 405.62B |
| 16 | ISRG | Intuitive Surgical, Inc. | 134.40B | -6.78% | 5,655,447 | 10.58B |
| 17 | VRTX | Vertex Pharmaceuticals Incorporated | 120.89B | -0.82% | 1,082,002 | 12.22B |
| 18 | SYK | Stryker Corporation | 119.25B | -6.15% | 4,052,843 | 25.27B |
| 19 | BMY | Bristol-Myers Squibb Company | 116.30B | -4.03% | 14,056,021 | 48.48B |
| 20 | SNY | Sanofi | 103.69B | -1.86% | 2,227,497 | 54.60B |
| 21 | GSK | GSK plc | 102.50B | -1.99% | 3,315,341 | 43.29B |
| 22 | MDT | Medtronic plc | 101.51B | -5.11% | 8,498,489 | 36.36B |
| 23 | MCK | McKesson Corporation | 94.06B | -1.10% | 1,115,814 | 403.43B |
| 24 | ELV | Elevance Health, Inc. | 92.68B | 0.38% | 2,192,844 | 200.42B |
| 25 | HCA | HCA Healthcare, Inc. | 80.66B | -6.95% | 4,227,615 | 76.39B |
| 26 | CI | The Cigna Group | 80.25B | -0.38% | 1,028,056 | 277.89B |
| 27 | REGN | Regeneron Pharmaceuticals, Inc. | 66.75B | -1.05% | 474,280 | 14.92B |
| 28 | BSX | Boston Scientific Corporation | 63.36B | -4.52% | 20,124,667 | 20.61B |
| 29 | COR | Cencora, Inc. | 58.81B | -1.26% | 1,141,782 | 328.68B |
| 30 | ARGX | argenx SE | 54.49B | -1.92% | 265,925 | 4.74B |
| 31 | CAH | Cardinal Health, Inc. | 53.89B | -1.52% | 3,127,419 | 250.74B |
| 32 | TAK | Takeda Pharmaceutical Company Limited | 51.97B | -0.61% | 5,055,633 | 28.34B |
| 33 | EW | Edwards Lifesciences Corporation | 51.87B | -1.85% | 5,249,221 | 6.30B |
| 34 | MDLN | Medline Inc. | 50.79B | -4.73% | 7,092,232 | 29.14B |
| 35 | HUM | Humana Inc. | 48.84B | 0.19% | 967,135 | 137.20B |
| 36 | IDXX | IDEXX Laboratories, Inc. | 42.65B | -4.17% | 769,695 | 4.45B |
| 37 | HLN | Haleon plc | 42.52B | -1.62% | 4,293,357 | 14.85B |
| 38 | BDX | Becton, Dickinson and Company | 41.51B | -2.07% | 1,908,090 | 22.23B |
| 39 | RVMD | Revolution Medicines, Inc. | 39.32B | 0.55% | 3,078,090 | - |
| 40 | NTRA | Natera, Inc. | 39.05B | -0.08% | 926,584 | 2.50B |
| 41 | A | Agilent Technologies, Inc. | 38.18B | 0.87% | 1,683,907 | 7.23B |
| 42 | ALNY | Alnylam Pharmaceuticals, Inc. | 37.55B | -2.36% | 1,083,414 | 4.29B |
| 43 | TEVA | Teva Pharmaceutical Industries Limited | 37.05B | -1.12% | 3,452,157 | 17.35B |
| 44 | WAT | Waters Corporation | 36.96B | 0.85% | 717,162 | 3.77B |
| 45 | IQV | IQVIA Holdings Inc. | 34.69B | 0.13% | 1,104,846 | 16.63B |
| 46 | ONC | BeOne Medicines AG | 34.08B | 0.86% | 439,874 | 5.74B |
| 47 | CNC | Centene Corporation | 33.93B | 0.63% | 3,362,612 | 178.33B |
| 48 | ALC | Alcon Inc. | 32.72B | -3.10% | 3,401,459 | 10.63B |
| 49 | RPRX | Royalty Pharma plc | 32.06B | -1.38% | 2,217,704 | 2.44B |
| 50 | VEEV | Veeva Systems Inc. | 31.37B | -1.89% | 1,691,889 | 3.32B |
| 51 | ZTS | Zoetis Inc. | 31.05B | -1.75% | 5,339,242 | 9.53B |
| 52 | ILMN | Illumina, Inc. | 28.93B | 0.61% | 1,934,241 | 4.39B |
| 53 | DXCM | DexCom, Inc. | 28.60B | -2.92% | 3,964,547 | 4.82B |
| 54 | BIIB | Biogen Inc. | 28.34B | -8.17% | 3,821,954 | 9.94B |
| 55 | GEHC | GE HealthCare Technologies Inc. | 28.05B | -5.59% | 11,968,876 | 20.98B |
| 56 | RMD | ResMed Inc. | 27.84B | -2.77% | 1,622,272 | 5.54B |
| 57 | MRNA | Moderna, Inc. | 26.76B | 0.64% | 5,759,798 | 2.23B |
| 58 | MTD | Mettler-Toledo International Inc. | 26.57B | 1.18% | 146,873 | 4.09B |
| 59 | WST | West Pharmaceutical Services, Inc. | 25.27B | -0.57% | 740,399 | 3.22B |
| 60 | ROIV | Roivant Sciences Ltd. | 25.11B | 1.16% | 3,979,938 | 8.26M |
| 61 | PHG | Koninklijke Philips N.V. | 25.07B | -4.68% | 1,459,068 | 20.34B |
| 62 | INSM | Insmed Incorporated | 23.87B | 0.89% | 1,826,299 | 819.56M |
| 63 | INCY | Incyte Corporation | 22.95B | 0.57% | 1,290,610 | 5.36B |
| 64 | BNTX | BioNTech SE | 22.86B | 0.37% | 910,640 | 3.23B |
| 65 | DGX | Quest Diagnostics Incorporated | 22.80B | -0.65% | 865,884 | 11.28B |
| 66 | LH | Labcorp Holdings Inc. | 22.61B | -0.36% | 751,715 | 14.14B |
| 67 | UTHR | United Therapeutics Corporation | 22.35B | -1.66% | 360,908 | 3.17B |
| 68 | GH | Guardant Health, Inc. | 21.23B | 1.08% | 1,324,047 | 1.08B |
| 69 | STE | STERIS plc | 20.34B | -3.83% | 886,161 | 5.94B |
| 70 | VTRS | Viatris Inc. | 18.99B | -0.49% | 9,204,807 | 14.56B |
| 71 | ZBH | Zimmer Biomet Holdings, Inc. | 17.61B | -3.24% | 3,214,211 | 8.41B |
| 72 | GMAB | Genmab A/S | 17.48B | -0.24% | 1,612,816 | 3.90B |
| 73 | NBIX | Neurocrine Biosciences, Inc. | 17.30B | -1.18% | 1,032,668 | 3.10B |
| 74 | ASND | Ascendis Pharma A/S | 16.49B | 0.13% | 512,538 | 998.25M |
| 75 | BBIO | BridgeBio Pharma, Inc. | 16.48B | 1.22% | 2,699,273 | 579.96M |
| 76 | THC | Tenet Healthcare Corporation | 15.82B | -5.71% | 3,000,573 | 21.46B |
| 77 | MEDP | Medpace Holdings, Inc. | 15.31B | 1.13% | 279,585 | 2.68B |
| 78 | JAZZ | Jazz Pharmaceuticals plc | 14.95B | 0.46% | 739,228 | 4.44B |
| 79 | DVA | DaVita Inc. | 14.92B | -1.35% | 771,225 | 13.84B |
| 80 | BTSG | BrightSpring Health Services, Inc. | 14.51B | 0.04% | 1,798,677 | 13.65B |
| 81 | EXEL | Exelixis, Inc. | 14.02B | -0.48% | 1,783,039 | 2.38B |
| 82 | COO | The Cooper Companies, Inc. | 13.36B | -3.94% | 2,169,420 | 4.23B |
| 83 | SOLV | Solventum Corporation | 13.21B | -1.47% | 760,441 | 8.26B |
| 84 | FMS | Fresenius Medical Care AG | 12.90B | -1.27% | 502,282 | 22.32B |
| 85 | ICLR | ICON Public Limited Company | 12.87B | 1.13% | 636,719 | 8.27B |
| 86 | ALGN | Align Technology, Inc. | 12.78B | -1.18% | 411,655 | 4.10B |
| 87 | ELAN | Elanco Animal Health Incorporated | 12.76B | 1.63% | 4,615,187 | 4.89B |
| 88 | MOH | Molina Healthcare, Inc. | 12.58B | -0.54% | 1,338,910 | 43.10B |
| 89 | SNN | Smith & Nephew plc | 12.58B | -4.02% | 1,963,879 | 6.16B |
| 90 | PEN | Penumbra, Inc. | 12.44B | -0.84% | 661,579 | 1.45B |
| 91 | RVTY | Revvity, Inc. | 12.41B | 0.09% | 994,729 | 2.90B |
| 92 | MDGL | Madrigal Pharmaceuticals, Inc. | 12.38B | 1.10% | 238,748 | 1.13B |
| 93 | AXSM | Axsome Therapeutics, Inc. | 12.11B | 3.06% | 471,898 | 708.24M |
| 94 | SMMT | Summit Therapeutics Inc. | 12.01B | 1.11% | 3,000,267 | - |
| 95 | ABVX | ABIVAX Société Anonyme | 11.71B | -0.79% | 922,715 | 5.67M |
| 96 | BMRN | BioMarin Pharmaceutical Inc. | 11.33B | -0.95% | 1,380,298 | 3.24B |
| 97 | BAX | Baxter International Inc. | 11.26B | -3.41% | 5,046,828 | 11.32B |
| 98 | CRL | Charles River Laboratories International, Inc. | 11.14B | 0.64% | 964,732 | 4.03B |
| 99 | CYTK | Cytokinetics, Incorporated | 11.12B | -0.38% | 1,424,977 | 105.82M |
| 100 | TECH | Bio-Techne Corporation | 11.10B | -0.18% | 2,938,523 | 1.21B |
| 101 | PODD | Insulet Corporation | 11.02B | -1.81% | 1,931,720 | 2.90B |
| 102 | RDY | Dr. Reddy's Laboratories Limited | 10.80B | -0.62% | 2,514,476 | 3.58B |
| 103 | EHC | Encompass Health Corporation | 10.79B | -1.19% | 1,348,851 | 6.07B |
| 104 | TEM | Tempus AI, Inc. | 10.54B | 4.90% | 3,629,243 | 1.36B |
| 105 | GMED | Globus Medical, Inc. | 10.29B | -4.93% | 3,021,216 | 3.10B |
| 106 | ARWR | Arrowhead Pharmaceuticals, Inc. | 10.13B | -2.97% | 1,621,327 | 622.01M |
| 107 | APGE | Apogee Therapeutics, Inc. | 10.04B | 0.10% | 1,288,749 | - |
| 108 | KRYS | Krystal Biotech, Inc. | 10.01B | -6.61% | 491,365 | 417.30M |
| 109 | HSIC | Henry Schein, Inc. | 9.90B | 1.31% | 1,365,156 | 13.38B |
| 110 | NUVL | Nuvalent, Inc. | 9.83B | 0.02% | 3,059,070 | - |
| 111 | CORT | Corcept Therapeutics Incorporated | 9.71B | 5.32% | 1,149,354 | 769.10M |
| 112 | ENSG | The Ensign Group, Inc. | 9.66B | -0.99% | 428,337 | 5.27B |
| 113 | OSCR | Oscar Health, Inc. | 9.36B | -1.68% | 3,498,141 | 13.30B |
| 114 | KYMR | Kymera Therapeutics, Inc. | 9.22B | 1.52% | 428,373 | 51.48M |
| 115 | PRAX | Praxis Precision Medicines, Inc. | 9.14B | 4.17% | 372,593 | 7.46M |
| 116 | BRKR | Bruker Corporation | 9.11B | 1.46% | 1,448,601 | 3.46B |
| 117 | IONS | Ionis Pharmaceuticals, Inc. | 9.08B | -3.21% | 4,650,270 | 1.06B |
| 118 | GKOS | Glaukos Corporation | 8.95B | -0.18% | 517,354 | 551.35M |
| 119 | HALO | Halozyme Therapeutics, Inc. | 8.90B | -1.39% | 1,772,386 | 1.51B |
| 120 | CRNX | Crinetics Pharmaceuticals, Inc. | 8.83B | 0.05% | 5,037,098 | 18.07M |
| 121 | UHS | Universal Health Services, Inc. | 8.73B | -5.59% | 1,652,471 | 17.76B |
| 122 | SYRE | Spyre Therapeutics, Inc. | 8.70B | 5.57% | 2,711,061 | - |
| 123 | ALKS | Alkermes plc | 8.60B | -0.52% | 1,750,045 | 1.56B |
| 124 | QGEN | Qiagen N.V. | 8.59B | 0.29% | 2,204,260 | 2.10B |
| 125 | PTGX | Protagonist Therapeutics, Inc. | 8.44B | 1.06% | 558,597 | 74.06M |
| 126 | RGEN | Repligen Corporation | 8.30B | 1.55% | 514,655 | 763.34M |
| 127 | IBRX | ImmunityBio, Inc. | 8.25B | 1.16% | 7,396,267 | 140.98M |
| 128 | ATR | AptarGroup, Inc. | 8.19B | 2.71% | 739,896 | 3.87B |
| 129 | HIMS | Hims & Hers Health, Inc. | 8.14B | 2.24% | 7,734,333 | 2.37B |
| 130 | PCVX | Vaxcyte, Inc. | 8.12B | -1.44% | 774,433 | - |
| 131 | BIO | Bio-Rad Laboratories, Inc. | 7.98B | 0.26% | 227,777 | 2.59B |
| 132 | IMVT | Immunovant, Inc. | 7.96B | 0.18% | 753,478 | - |
| 133 | HQY | HealthEquity, Inc. | 7.90B | -1.21% | 1,041,457 | 1.34B |
| 134 | TGTX | TG Therapeutics, Inc. | 7.78B | -0.22% | 1,991,172 | 700.35M |
| 135 | AVTR | Avantor, Inc. | 7.71B | 6.91% | 13,327,946 | 6.55B |
| 136 | RYTM | Rhythm Pharmaceuticals, Inc. | 7.54B | 2.30% | 743,085 | 217.17M |
| 137 | MIRM | Mirum Pharmaceuticals, Inc. | 7.37B | 1.55% | 694,185 | 569.61M |
| 138 | PACS | PACS Group, Inc. | 7.11B | 3.88% | 1,274,414 | 5.43B |
| 139 | HNGE | Hinge Health, Inc. | 6.91B | -0.77% | 1,349,087 | 646.34M |
| 140 | LQDA | Liquidia Corporation | 6.80B | 7.41% | 1,144,413 | 288.07M |
| 141 | LNTH | Lantheus Holdings, Inc. | 6.66B | -2.87% | 731,081 | 1.55B |
| 142 | COGT | Cogent Biosciences, Inc. | 6.58B | 2.80% | 2,031,340 | - |
| 143 | XENE | Xenon Pharmaceuticals Inc. | 6.51B | -0.62% | 1,035,393 | 7.50M |
| 144 | CHE | Chemed Corporation | 6.50B | -0.08% | 165,917 | 2.54B |
| 145 | PTCT | PTC Therapeutics, Inc. | 6.48B | -4.02% | 1,601,082 | 827.11M |
| 146 | SRRK | Scholar Rock Holding Corporation | 6.44B | -1.68% | 1,074,364 | - |
| 147 | CGON | CG Oncology, Inc. | 6.33B | -1.01% | 1,103,813 | 5.07M |
| 148 | DFTX | Definium Therapeutics, Inc. | 6.10B | 5.34% | 1,390,124 | - |
| 149 | GRFS | Grifols, S.A. | 6.10B | -2.50% | 532,955 | 8.58B |
| 150 | ERAS | Erasca, Inc. | 6.06B | 8.94% | 10,608,590 | - |
| 151 | LGND | Ligand Pharmaceuticals Incorporated | 5.96B | -2.68% | 643,971 | 274.48M |
| 152 | TXG | 10x Genomics, Inc. | 5.81B | 9.62% | 3,791,093 | 638.78M |
| 153 | BLTE | Belite Bio, Inc | 5.77B | -0.24% | 106,970 | - |
| 154 | TFX | Teleflex Incorporated | 5.76B | -4.57% | 365,188 | 2.13B |
| 155 | TWST | Twist Bioscience Corporation | 5.76B | 2.41% | 1,292,837 | 409.48M |
| 156 | BLLN | BillionToOne, Inc. | 5.74B | 1.31% | 556,442 | 354.54M |
| 157 | BLCO | Bausch + Lomb Corporation | 5.69B | -1.54% | 338,910 | 5.21B |
| 158 | DNTH | Dianthus Therapeutics, Inc. | 5.54B | 2.68% | 1,189,502 | 1.34M |
| 159 | CELC | Celcuity Inc. | 5.42B | 6.99% | 2,116,429 | - |
| 160 | STVN | Stevanato Group S.p.A. | 5.41B | 0.20% | 254,207 | 1.39B |
| 161 | AMRX | Amneal Pharmaceuticals, Inc. | 5.32B | -2.85% | 1,487,491 | 3.05B |
| 162 | TVTX | Travere Therapeutics, Inc. | 5.31B | 1.37% | 880,457 | 536.20M |
| 163 | ORKA | Oruka Therapeutics, Inc. | 5.28B | 3.44% | 892,862 | - |
| 164 | SHC | Sotera Health Company | 5.07B | -2.20% | 3,517,189 | 1.19B |
| 165 | CRSP | CRISPR Therapeutics AG | 4.97B | -0.34% | 1,700,290 | 4.10M |
| 166 | LEGN | Legend Biotech Corporation | 4.97B | -0.31% | 1,564,904 | 1.14B |
| 167 | RDNT | RadNet, Inc. | 4.94B | -0.84% | 1,038,924 | 2.14B |
| 168 | INDV | Indivior Pharmaceuticals, Inc. | 4.90B | 0.05% | 942,061 | 1.29B |
| 169 | CAI | Caris Life Sciences, Inc. | 4.79B | -0.64% | 3,589,770 | 907.29M |
| 170 | KNSA | Kiniksa Pharmaceuticals International, plc | 4.77B | 1.71% | 550,008 | 754.05M |
| 171 | MANE | Veradermics, Incorporated | 4.60B | -0.01% | 524,868 | - |
| 172 | VCYT | Veracyte, Inc. | 4.52B | -1.50% | 963,692 | 541.74M |
| 173 | VKTX | Viking Therapeutics, Inc. | 4.41B | -0.39% | 1,310,288 | - |
| 174 | ALHC | Alignment Healthcare, Inc. | 4.38B | 4.02% | 3,850,839 | 4.26B |
| 175 | ACAD | ACADIA Pharmaceuticals Inc. | 4.36B | -0.04% | 1,203,143 | 1.10B |
| 176 | LIVN | LivaNova PLC | 4.35B | -4.65% | 820,715 | 1.43B |
| 177 | TNGX | Tango Therapeutics, Inc. | 4.29B | 4.55% | 1,904,812 | 56.99M |
| 178 | EWTX | Edgewise Therapeutics, Inc. | 4.27B | -3.73% | 1,193,570 | - |
| 179 | WAY | Waystar Holding Corp. | 4.26B | -3.65% | 1,910,147 | 1.16B |
| 180 | NVST | Envista Holdings Corporation | 4.25B | -0.42% | 2,382,000 | 2.81B |
| 181 | MMSI | Merit Medical Systems, Inc. | 4.24B | -3.06% | 511,670 | 1.54B |
| 182 | MMED | MiniMed Group, Inc. | 4.22B | -6.58% | 951,535 | 3.10B |
| 183 | LFST | LifeStance Health Group, Inc. | 4.18B | -0.83% | 3,008,474 | 1.49B |
| 184 | RLAY | Relay Therapeutics, Inc. | 4.16B | 1.87% | 1,683,249 | 10.68M |
| 185 | DOCS | Doximity, Inc. | 3.99B | -2.20% | 3,402,409 | 644.86M |
| 186 | PBLS | Parabilis Medicines, Inc. | 3.97B | 5.13% | 538,692 | - |
| 187 | CON | Concentra Group Holdings Parent, Inc. | 3.95B | -1.56% | 1,029,582 | 2.23B |
| 188 | DYN | Dyne Therapeutics, Inc. | 3.93B | 0.59% | 2,114,868 | - |
| 189 | NAMS | NewAmsterdam Pharma Company N.V. | 3.89B | 0.03% | 636,630 | 22.57M |
| 190 | CPRX | Catalyst Pharmaceuticals, Inc. | 3.85B | 0.03% | 15,451,073 | 596.96M |
| 191 | ICUI | ICU Medical, Inc. | 3.84B | -2.61% | 343,131 | 2.16B |
| 192 | TLX | Telix Pharmaceuticals Limited | 3.75B | 0.46% | 92,955 | 803.79M |
| 193 | IRTC | iRhythm Holdings, Inc. | 3.70B | -5.17% | 534,286 | 787.85M |
| 194 | ELVN | Enliven Therapeutics, Inc. | 3.61B | 1.69% | 741,745 | - |
| 195 | GPCR | Structure Therapeutics Inc. | 3.60B | -2.03% | 533,617 | - |
| 196 | DNLI | Denali Therapeutics Inc. | 3.59B | -14.46% | 5,623,548 | - |
| 197 | RCUS | Arcus Biosciences, Inc. | 3.56B | 0.93% | 801,993 | 236.00M |
| 198 | OGN | Organon & Co. | 3.55B | - | 2,040,232 | 6.16B |
| 199 | PRVA | Privia Health Group, Inc. | 3.53B | 0.50% | 1,042,481 | 2.25B |
| 200 | IDYA | IDEAYA Biosciences, Inc. | 3.48B | 1.38% | 1,135,554 | 225.27M |
| 201 | ALMS | Alumis Inc. | 3.48B | -2.92% | 1,688,665 | 8.40M |
| 202 | ADPT | Adaptive Biotechnologies Corporation | 3.43B | 1.95% | 1,870,277 | 295.41M |
| 203 | WRBY | Warby Parker Inc. | 3.39B | 0.73% | 2,091,975 | 890.57M |
| 204 | BKD | Brookdale Senior Living Inc. | 3.39B | -1.46% | 5,250,193 | 3.00B |
| 205 | HAE | Haemonetics Corporation | 3.38B | -3.23% | 650,537 | 1.33B |
| 206 | ARQT | Arcutis Biotherapeutics, Inc. | 3.35B | -1.14% | 763,804 | 415.62M |
| 207 | OPCH | Option Care Health, Inc. | 3.35B | -1.61% | 1,713,314 | 5.67B |
| 208 | NHC | National HealthCare Corporation | 3.29B | 1.40% | 89,306 | 1.53B |
| 209 | ITGR | Integer Holdings Corporation | 3.17B | -3.19% | 450,235 | 1.86B |
| 210 | RARE | Ultragenyx Pharmaceutical Inc. | 3.15B | -3.58% | 1,068,452 | 670.00M |
| 211 | GRAL | GRAIL, Inc. | 3.14B | 1.84% | 358,943 | 156.12M |
| 212 | VERA | Vera Therapeutics, Inc. | 3.10B | 3.93% | 2,538,555 | - |
| 213 | BEAM | Beam Therapeutics Inc. | 3.07B | -0.35% | 1,979,803 | 164.01M |
| 214 | CLDX | Celldex Therapeutics, Inc. | 3.00B | -0.93% | 699,434 | 865.00K |
| 215 | ACHC | Acadia Healthcare Company, Inc. | 2.91B | 3.40% | 3,675,768 | 3.37B |
| 216 | IRON | Disc Medicine, Inc. | 2.87B | -1.28% | 350,807 | - |
| 217 | QURE | uniQure N.V. | 2.85B | 1.02% | 967,458 | 18.09M |
| 218 | RGC | Regencell Bioscience Holdings Limited | 2.80B | 11.88% | 448,619 | - |
| 219 | SUPN | Supernus Pharmaceuticals, Inc. | 2.71B | -1.46% | 803,179 | 776.83M |
| 220 | KOD | Kodiak Sciences Inc. | 2.70B | 5.26% | 880,235 | - |
| 221 | MBX | MBX Biosciences, Inc. | 2.69B | -5.75% | 1,341,076 | - |
| 222 | SLS | SELLAS Life Sciences Group, Inc. | 2.63B | 6.10% | 6,004,135 | - |
| 223 | TMDX | TransMedics Group, Inc. | 2.58B | -1.52% | 672,834 | 635.89M |
| 224 | IMNM | Immunome, Inc. | 2.56B | -0.92% | 1,658,458 | 4.02M |
| 225 | ESTA | Establishment Labs Holdings Inc. | 2.55B | -1.49% | 314,044 | 229.58M |
| 226 | XRAY | DENTSPLY SIRONA Inc. | 2.54B | -0.63% | 5,650,303 | 3.68B |
| 227 | TRVI | Trevi Therapeutics, Inc. | 2.54B | 8.41% | 2,468,511 | - |
| 228 | CLOV | Clover Health Investments, Corp. | 2.54B | 5.47% | 4,853,677 | 2.21B |
| 229 | PGNY | Progyny, Inc. | 2.53B | 1.19% | 1,198,306 | 1.29B |
| 230 | GRDN | Guardian Pharmacy Services, Inc. | 2.51B | -1.54% | 299,971 | 1.46B |
| 231 | BCRX | BioCryst Pharmaceuticals, Inc. | 2.48B | -1.72% | 3,929,394 | 885.72M |
| 232 | KLRA | Kailera Therapeutics, Inc. | 2.46B | -4.81% | 305,044 | - |
| 233 | ASTH | Astrana Health, Inc. | 2.43B | 2.85% | 638,515 | 3.53B |
| 234 | TARS | Tarsus Pharmaceuticals, Inc. | 2.41B | -5.40% | 2,061,420 | 535.08M |
| 235 | PHVS | Pharvaris N.V. | 2.41B | -1.85% | 279,091 | - |
| 236 | MLYS | Mineralys Therapeutics, Inc. | 2.40B | -1.12% | 555,876 | - |
| 237 | NRIX | Nurix Therapeutics, Inc. | 2.38B | 1.19% | 1,563,822 | 36.77M |
| 238 | AGIO | Agios Pharmaceuticals, Inc. | 2.37B | -1.55% | 666,265 | 66.05M |
| 239 | VCEL | Vericel Corporation | 2.35B | -2.95% | 629,974 | 292.09M |
| 240 | NKTR | Nektar Therapeutics | 2.27B | -1.68% | 800,702 | 55.63M |
| 241 | BHVN | Biohaven Ltd. | 2.25B | -1.52% | 1,433,513 | - |
| 242 | LMAT | LeMaitre Vascular, Inc. | 2.24B | -2.42% | 224,944 | 256.28M |
| 243 | PBH | Prestige Consumer Healthcare Inc. | 2.24B | -3.36% | 412,040 | 1.09B |
| 244 | HTFL | HeartFlow, Inc. | 2.20B | -2.56% | 1,970,442 | 191.42M |
| 245 | ZLAB | Zai Lab Limited | 2.17B | -1.63% | 473,516 | 453.28M |
| 246 | MESO | Mesoblast Limited | 2.16B | 3.21% | 267,109 | 65.38M |
| 247 | PVLA | Palvella Therapeutics, Inc. | 2.15B | 2.50% | 238,960 | - |
| 248 | SNDX | Syndax Pharmaceuticals, Inc. | 2.14B | 5.42% | 2,066,190 | 217.17M |
| 249 | OCUL | Ocular Therapeutix, Inc. | 2.12B | -1.82% | 1,414,457 | 52.04M |
| 250 | VRDN | Viridian Therapeutics, Inc. | 2.11B | 0.47% | 1,123,399 | 70.92M |
| 251 | NEOG | Neogen Corporation | 2.10B | 0.21% | 1,634,919 | 870.56M |
| 252 | NBTX | Nanobiotix S.A. | 2.10B | 6.36% | 73,229 | 38.27M |
| 253 | OMCL | Omnicell, Inc. | 2.09B | -1.59% | 648,685 | 1.23B |
| 254 | ATAI | AtaiBeckley Inc. | 2.09B | 14.08% | 11,529,077 | 3.49M |
| 255 | AXGN | Axogen, Inc. | 2.06B | -1.82% | 1,156,146 | 238.11M |
| 256 | ABCL | AbCellera Biologics Inc. | 2.06B | 3.37% | 4,144,926 | 79.21M |
| 257 | ADMA | ADMA Biologics, Inc. | 2.06B | -1.11% | 2,677,813 | 509.86M |
| 258 | AUPH | Aurinia Pharmaceuticals Inc. | 2.06B | -0.31% | 815,248 | 298.30M |
| 259 | NUVB | Nuvation Bio Inc. | 2.05B | 2.25% | 7,294,674 | 143.05M |
| 260 | AGL | agilon health, inc. | 2.05B | 5.84% | 365,077 | 5.82B |
| 261 | AVAH | Aveanna Healthcare Holdings Inc. | 2.03B | -3.41% | 1,834,417 | 2.52B |
| 262 | BFLY | Butterfly Network, Inc. | 2.03B | -4.32% | 7,014,456 | 102.92M |
| 263 | AMLX | Amylyx Pharmaceuticals, Inc. | 2.02B | 4.54% | 1,923,450 | -665.00K |
| 264 | COAG | Hemab Therapeutics Holdings, Inc. | 2.02B | 9.62% | 319,539 | - |
| 265 | HRMY | Harmony Biosciences Holdings, Inc. | 2.02B | -2.05% | 932,742 | 899.11M |
| 266 | HCM | HUTCHMED (China) Limited | 1.99B | 0.99% | 20,719 | 548.51M |
| 267 | KARD | Kardigan, Inc. | 1.99B | -5.40% | 275,696 | - |
| 268 | ADUS | Addus HomeCare Corporation | 1.98B | -0.33% | 225,366 | 1.45B |
| 269 | RAPP | Rapport Therapeutics, Inc. | 1.98B | 2.14% | 402,446 | 20.00M |
| 270 | GLUE | Monte Rosa Therapeutics, Inc. | 1.98B | 6.73% | 1,122,824 | 42.95M |
| 271 | SGRY | Surgery Partners, Inc. | 1.96B | -5.38% | 2,163,891 | 3.34B |
| 272 | TYRA | Tyra Biosciences, Inc. | 1.96B | 0.64% | 564,775 | - |
| 273 | LKFT | Lakefront Biotherapeutics NV | 1.94B | -1.11% | 165,287 | 1.20B |
| 274 | MD | Pediatrix Medical Group, Inc. | 1.93B | -7.77% | 1,247,331 | 1.93B |
| 275 | SION | Sionna Therapeutics, Inc. | 1.92B | -3.09% | 273,600 | - |
| 276 | URGN | UroGen Pharma Ltd. | 1.91B | -0.81% | 551,310 | 140.49M |
| 277 | DMRA | Damora Therapeutics, Inc. | 1.91B | 10.68% | 519,828 | - |
| 278 | SRPT | Sarepta Therapeutics, Inc. | 1.90B | -4.57% | 2,930,689 | 2.18B |
| 279 | ALMR | Alamar Biosciences, Inc. | 1.87B | -1.28% | 220,225 | 87.16M |
| 280 | SNDA | Sonida Senior Living, Inc. | 1.87B | -0.60% | 466,897 | 367.34M |
| 281 | NTLA | Intellia Therapeutics, Inc. | 1.86B | 2.15% | 3,995,666 | 66.09M |
| 282 | WGS | GeneDx Holdings Corp. | 1.85B | -2.22% | 919,530 | 442.68M |
| 283 | NEO | NeoGenomics, Inc. | 1.85B | 0.85% | 1,466,004 | 745.97M |
| 284 | ANAB | AnaptysBio, Inc. | 1.85B | -10.46% | 617,897 | 232.39M |
| 285 | BCAX | Bicara Therapeutics Inc. | 1.85B | -0.18% | 326,877 | - |
| 286 | GHRS | GH Research PLC | 1.84B | 5.60% | 93,805 | - |
| 287 | PGEN | Precigen, Inc. | 1.83B | -0.97% | 2,887,818 | 31.60M |
| 288 | TSHA | Taysha Gene Therapies, Inc. | 1.82B | 5.95% | 3,899,078 | 7.47M |
| 289 | GENB | Generate Biomedicines, Inc. | 1.82B | -0.49% | 382,939 | 30.30M |
| 290 | ZBIO | Zenas BioPharma, Inc. | 1.82B | 3.23% | 684,298 | 10.00M |
| 291 | STOK | Stoke Therapeutics, Inc. | 1.81B | -1.12% | 551,116 | 32.08M |
| 292 | CMPS | COMPASS Pathways plc | 1.81B | 1.52% | 2,761,279 | - |
| 293 | NVCR | NovoCure Limited | 1.80B | -3.36% | 1,145,275 | 674.41M |
| 294 | UFPT | UFP Technologies, Inc. | 1.78B | -3.01% | 249,785 | 608.85M |
| 295 | BHC | Bausch Health Companies Inc. | 1.77B | -2.06% | 1,928,677 | 10.53B |
| 296 | RXRX | Recursion Pharmaceuticals, Inc. | 1.77B | 1.21% | 24,694,238 | 66.41M |
| 297 | ZYME | Zymeworks Inc. | 1.77B | -1.12% | 340,356 | 81.26M |
| 298 | PLSE | Pulse Biosciences, Inc. | 1.76B | -1.66% | 216,779 | 751.00K |
| 299 | IOVA | Iovance Biotherapeutics, Inc. | 1.75B | -2.72% | 13,108,435 | 285.61M |
| 300 | TRLV | Trulieve Cannabis Corp. | 1.74B | 0.22% | 751,139 | 1.17B |
| 301 | ATRC | AtriCure, Inc. | 1.74B | -1.38% | 1,095,519 | 552.16M |
| 302 | ABSI | Absci Corporation | 1.73B | 0.20% | 3,252,938 | 1.84M |
| 303 | AAPG | Ascentage Pharma Group International | 1.73B | -1.84% | 3,048 | 82.08M |
| 304 | MPLT | MapLight Therapeutics, Inc. | 1.72B | 3.66% | 269,490 | - |
| 305 | ANIP | ANI Pharmaceuticals, Inc. | 1.71B | -0.65% | 239,023 | 923.71M |
| 306 | FTRE | Fortrea Holdings Inc. | 1.71B | 0.95% | 725,941 | 2.71B |
| 307 | IMCR | Immunocore Holdings plc | 1.70B | 3.02% | 976,795 | 412.81M |
| 308 | MRVI | Maravai LifeSciences Holdings, Inc. | 1.68B | 2.36% | 6,348,539 | 204.73M |
| 309 | TDOC | Teladoc Health, Inc. | 1.67B | -3.94% | 3,258,323 | 2.51B |
| 310 | MAZE | Maze Therapeutics, Inc. | 1.65B | 2.40% | 406,305 | 20.00M |
| 311 | HCSG | Healthcare Services Group, Inc. | 1.65B | -0.25% | 437,312 | 1.85B |
| 312 | MLTX | MoonLake Immunotherapeutics | 1.61B | -4.36% | 1,075,888 | - |
| 313 | INVA | Innoviva, Inc. | 1.60B | -2.12% | 805,540 | 420.69M |
| 314 | VIR | Vir Biotechnology, Inc. | 1.60B | -2.37% | 1,640,977 | 65.50M |
| 315 | INNV | InnovAge Holding Corp. | 1.58B | 3.02% | 354,030 | 949.17M |
| 316 | PSNL | Personalis, Inc. | 1.57B | -0.07% | 3,441,249 | 64.52M |
| 317 | SEPN | Septerna, Inc. | 1.56B | 0.52% | 588,311 | 72.26M |
| 318 | HROW | Harrow, Inc. | 1.54B | -1.05% | 303,918 | 268.68M |
| 319 | AVBP | ArriVent BioPharma, Inc. | 1.52B | -3.27% | 288,404 | - |
| 320 | CDNA | CareDx, Inc. | 1.49B | 0.59% | 856,887 | 412.82M |
| 321 | SVRA | Savara Inc. | 1.44B | -0.87% | 1,829,603 | - |
| 322 | IART | Integra LifeSciences Holdings Corporation | 1.43B | -0.97% | 1,064,188 | 1.64B |
| 323 | XERS | Xeris Biopharma Holdings, Inc. | 1.43B | 1.47% | 1,206,533 | 314.85M |
| 324 | ENOV | Enovis Corporation | 1.42B | -6.10% | 859,519 | 2.28B |
| 325 | INSP | Inspire Medical Systems, Inc. | 1.42B | -4.30% | 580,055 | 915.25M |
| 326 | KMTS | Kestra Medical Technologies, Ltd. | 1.41B | -2.34% | 400,630 | 83.72M |
| 327 | ARDT | Ardent Health, Inc. | 1.40B | -2.68% | 635,961 | 6.43B |
| 328 | BLFS | BioLife Solutions, Inc. | 1.40B | 1.96% | 448,952 | 101.66M |
| 329 | OMDA | Omada Health, Inc. | 1.39B | -0.26% | 553,786 | 283.30M |
| 330 | AKTS | Aktis Oncology, Inc. | 1.39B | -1.58% | 745,999 | 8.28M |
| 331 | NVAX | Novavax, Inc. | 1.38B | -5.50% | 3,769,803 | 596.34M |
| 332 | PNTG | The Pennant Group, Inc. | 1.38B | -0.25% | 290,368 | 1.02B |
| 333 | ATEC | Alphatec Holdings, Inc. | 1.38B | -7.91% | 2,860,375 | 787.08M |
| 334 | PRGO | Perrigo Company plc | 1.37B | -2.65% | 2,635,046 | 4.18B |
| 335 | INBX | Inhibrx Biosciences, Inc. | 1.37B | 1.13% | 352,332 | 1.30M |
| 336 | STAA | STAAR Surgical Company | 1.36B | -1.58% | 506,707 | 290.38M |
| 337 | AHCO | AdaptHealth Corp. | 1.36B | -0.97% | 847,393 | 3.29B |
| 338 | PAHC | Phibro Animal Health Corporation | 1.34B | 0.12% | 224,881 | 1.50B |
| 339 | AHG | Akso Health Group | 1.30B | 2.70% | 2,594 | 14.84M |
| 340 | IMTX | Immatics N.V. | 1.28B | 1.30% | 193,396 | 43.00M |
| 341 | ARDX | Ardelyx, Inc. | 1.27B | 0.39% | 2,639,459 | 427.68M |
| 342 | JBIO | Jade Biosciences, Inc. | 1.27B | 0.19% | 1,166,546 | - |
| 343 | AMN | AMN Healthcare Services, Inc. | 1.26B | -4.36% | 912,309 | 3.42B |
| 344 | CRVS | Corvus Pharmaceuticals, Inc. | 1.26B | 1.77% | 1,416,844 | - |
| 345 | CNMD | CONMED Corporation | 1.26B | -1.56% | 994,270 | 1.37B |
| 346 | AVLN | Avalyn Pharma Inc. | 1.25B | 1.58% | 201,465 | - |
| 347 | NUTX | Nutex Health Inc. | 1.23B | -0.44% | 91,236 | 879.95M |
| 348 | SDGR | Schrödinger, Inc. | 1.21B | -1.71% | 895,232 | 254.91M |
| 349 | QDEL | QuidelOrtho Corporation | 1.20B | -1.29% | 772,773 | 2.66B |
| 350 | TRAX | First Tracks Biotherapeutics, Inc. | 1.20B | -1.83% | 692,481 | - |
| 351 | MNKD | MannKind Corporation | 1.20B | -3.96% | 4,606,609 | 360.78M |
| 352 | CAPR | Capricor Therapeutics, Inc. | 1.20B | 0.34% | 993,875 | 11.13M |
| 353 | WVE | Wave Life Sciences Ltd. | 1.18B | 3.03% | 2,051,745 | 71.80M |
| 354 | ALVO | Alvotech | 1.18B | -2.37% | 704,810 | 562.04M |
| 355 | AZTA | Azenta, Inc. | 1.17B | -2.34% | 856,211 | 596.48M |
| 356 | IRMD | IRADIMED CORPORATION | 1.17B | -6.16% | 159,291 | 86.28M |
| 357 | AVNS | Avanos Medical, Inc. | 1.17B | - | 357,269 | 715.90M |
| 358 | MGTX | MeiraGTx Holdings plc | 1.15B | 0.81% | 1,271,411 | 79.76M |
| 359 | EYPT | EyePoint, Inc. | 1.15B | -3.85% | 1,039,863 | 7.61M |
| 360 | COLL | Collegium Pharmaceutical, Inc. | 1.14B | 0.57% | 549,376 | 796.33M |
| 361 | AORT | Artivion, Inc. | 1.12B | -3.75% | 400,701 | 458.69M |
| 362 | DRTS | Alpha Tau Medical Ltd. | 1.11B | 1.31% | 384,140 | - |
| 363 | XNCR | Xencor, Inc. | 1.11B | -0.07% | 575,020 | 97.36M |
| 364 | PRCT | PROCEPT BioRobotics Corporation | 1.10B | -9.00% | 1,875,005 | 322.02M |
| 365 | SPTX | Seaport Therapeutics, Inc. | 1.09B | 1.69% | 100,650 | - |
| 366 | ORIC | ORIC Pharmaceuticals, Inc. | 1.09B | 0.86% | 942,010 | - |
| 367 | CGEM | Cullinan Therapeutics, Inc. | 1.09B | -0.56% | 633,521 | - |
| 368 | GMRS | GMR Solutions Inc. | 1.09B | -2.84% | 310,603 | 5.83B |
| 369 | SANA | Sana Biotechnology, Inc. | 1.07B | -1.92% | 1,988,842 | - |
| 370 | USPH | U.S. Physical Therapy, Inc. | 1.07B | -2.22% | 250,500 | 787.69M |
| 371 | TNDM | Tandem Diabetes Care, Inc. | 1.06B | -4.37% | 1,864,715 | 1.03B |
| 372 | FBRX | Forte Biosciences, Inc. | 1.06B | -2.09% | 673,359 | - |
| 373 | LMRI | Lumexa Imaging Holdings, Inc. | 1.05B | -2.15% | 380,009 | 1.03B |
| 374 | CERT | Certara, Inc. | 1.04B | -1.77% | 2,179,862 | 419.75M |
| 375 | OLMA | Olema Pharmaceuticals, Inc. | 1.04B | - | 786,090 | - |
| 376 | CRON | Cronos Group Inc. | 1.03B | - | 537,640 | 159.54M |
| 377 | IVA | Inventiva S.A. | 1.03B | 2.33% | 1,276,345 | 7.94M |
| 378 | ETON | Eton Pharmaceuticals, Inc. | 1.03B | 0.46% | 465,488 | 86.93M |
| 379 | GDRX | GoodRx Holdings, Inc. | 1.02B | -0.99% | 568,572 | 787.89M |
| 380 | BIOA | BioAge Labs, Inc. | 1.01B | 4.54% | 482,825 | 10.32M |
| 381 | VOR | Vor Biopharma Inc. | 1.00B | 2.61% | 896,192 | - |
| 382 | KURA | Kura Oncology, Inc. | 997.82M | 3.02% | 1,570,560 | 71.64M |
| 383 | PCRX | Pacira BioSciences, Inc. | 984.09M | -2.08% | 464,191 | 734.86M |
| 384 | ANRO | Alto Neuroscience, Inc. | 975.61M | -0.82% | 559,916 | - |
| 385 | GLAS | Glass House Brands Inc. | 971.56M | 0.09% | 145,694 | 177.68M |
| 386 | AVTX | Avalo Therapeutics, Inc. | 968.26M | -2.59% | 835,800 | 59.00K |
| 387 | BVS | Bioventus Inc. | 965.66M | -4.23% | 517,846 | 576.30M |
| 388 | JANX | Janux Therapeutics, Inc. | 962.33M | -2.23% | 830,291 | 13.73M |
| 389 | DBVT | DBV Technologies S.A. | 959.63M | -0.38% | 243,026 | 5.74M |
| 390 | SLDB | Solid Biosciences Inc. | 948.07M | -0.93% | 895,416 | - |
| 391 | PHAR | Pharming Group N.V. | 942.72M | -2.58% | 4,138 | 369.49M |
| 392 | LXRX | Lexicon Pharmaceuticals, Inc. | 941.70M | -2.30% | 1,518,482 | 69.64M |
| 393 | OPK | OPKO Health, Inc. | 921.21M | -0.81% | 3,110,951 | 581.12M |
| 394 | LBRX | LB Pharmaceuticals Inc | 918.23M | -0.71% | 209,258 | - |
| 395 | ABUS | Arbutus Biopharma Corporation | 910.65M | -1.18% | 1,670,329 | 191.45M |
| 396 | ANNX | Annexon, Inc. | 909.33M | -1.42% | 5,531,614 | - |
| 397 | GERN | Geron Corporation | 885.30M | -2.82% | 11,601,054 | 196.12M |
| 398 | TBPH | Theravance Biopharma, Inc. | 876.93M | 0.12% | 535,896 | 109.78M |
| 399 | PHAT | Phathom Pharmaceuticals, Inc. | 876.51M | 1.05% | 1,027,117 | 204.89M |
| 400 | TALK | Talkspace, Inc. | 874.42M | -0.19% | 1,215,874 | 238.37M |
| 401 | AVR | Anteris Technologies Global Corp. | 871.83M | -4.38% | 759,419 | 1.85M |
| 402 | INMD | InMode Ltd. | 857.61M | -1.52% | 599,008 | 374.64M |
| 403 | FTH | Faeth Therapeutics, Inc. | 853.79M | -0.72% | 233,673 | - |
| 404 | DSGN | Design Therapeutics, Inc. | 853.79M | -1.37% | 579,374 | - |
| 405 | HSTM | HealthStream, Inc. | 830.30M | -1.04% | 139,523 | 311.78M |
| 406 | AMPH | Amphastar Pharmaceuticals, Inc. | 829.17M | -2.51% | 321,516 | 720.53M |
| 407 | ODTX | Odyssey Therapeutics, Inc. | 828.77M | -1.70% | 450,026 | 1.06M |
| 408 | REPL | Replimune Group, Inc. | 828.54M | -0.70% | 3,208,199 | - |
| 409 | CTMX | CytomX Therapeutics, Inc. | 796.79M | -1.08% | 4,592,190 | 35.54M |
| 410 | TENX | Tenax Therapeutics, Inc. | 794.99M | -2.63% | 1,221,814 | - |
| 411 | OCS | Oculis Holding AG | 780.82M | -1.67% | 305,832 | 1.40M |
| 412 | NGNE | Neurogene Inc. | 778.74M | 1.98% | 243,147 | 925.00K |
| 413 | AURA | Aura Biosciences, Inc. | 772.10M | - | 620,093 | - |
| 414 | ZVRA | Zevra Therapeutics, Inc. | 772.04M | -0.91% | 783,630 | 122.29M |
| 415 | EVO | Evotec SE | 762.74M | -11.93% | 270,384 | 859.03M |
| 416 | RIGL | Rigel Pharmaceuticals, Inc. | 761.73M | -0.31% | 270,803 | 299.77M |
| 417 | IMMX | Immix Biopharma, Inc. | 760.31M | 1.52% | 1,176,430 | - |
| 418 | OMER | Omeros Corporation | 759.94M | 4.90% | 1,354,416 | 9.89M |
| 419 | ACRS | Aclaris Therapeutics, Inc. | 758.37M | -1.27% | 824,068 | 8.37M |
| 420 | CLYM | Climb Bio, Inc. | 758.13M | 0.23% | 813,535 | - |
| 421 | SPRY | ARS Pharmaceuticals, Inc. | 755.70M | -1.68% | 1,834,500 | 98.99M |
| 422 | BBNX | Beta Bionics, Inc. | 751.31M | -0.53% | 1,337,930 | 110.24M |
| 423 | SIBN | SI-BONE, Inc. | 749.95M | -5.27% | 611,208 | 206.22M |
| 424 | DRUG | Bright Minds Biosciences Inc. | 743.89M | -2.50% | 242,798 | - |
| 425 | SSII | SS Innovations International, Inc. | 734.48M | 0.82% | 144,102 | 48.47M |
| 426 | CBLL | CeriBell, Inc. | 725.84M | -2.00% | 383,044 | 95.07M |
| 427 | CADL | Candel Therapeutics, Inc. | 723.18M | 2.39% | 1,412,212 | - |
| 428 | XOMA | XOMA Royalty Corporation | 710.16M | - | - | 48.56M |
| 429 | SLBT | SL Science Holding Limited | 709.53M | 1.39% | 59,898 | - |
| 430 | GYRE | Gyre Therapeutics, Inc. | 706.84M | - | 78,543 | 117.05M |
| 431 | BBOT | BridgeBio Oncology Therapeutics, Inc. | 706.54M | 3.52% | 418,054 | - |
| 432 | CSTL | Castle Biosciences, Inc. | 701.23M | 0.61% | 250,210 | 339.92M |
| 433 | EVH | Evolent Health, Inc. | 696.26M | 4.56% | 2,204,382 | 1.89B |
| 434 | MNPR | Monopar Therapeutics Inc. | 668.47M | -3.43% | 488,839 | - |
| 435 | SGP | SpyGlass Pharma, Inc. | 668.33M | 0.45% | 162,411 | - |
| 436 | PHR | Phreesia, Inc. | 663.86M | -2.63% | 591,771 | 495.59M |
| 437 | TECX | Tectonic Therapeutic, Inc. | 656.84M | 1.37% | 263,142 | - |
| 438 | IRWD | Ironwood Pharmaceuticals, Inc. | 655.16M | -5.46% | 2,102,126 | 361.51M |
| 439 | RLMD | Relmada Therapeutics, Inc. | 651.37M | -3.72% | 959,532 | - |
| 440 | CRMD | CorMedix Inc. | 648.80M | -0.60% | 796,748 | 400.05M |
| 441 | ACHV | Achieve Life Sciences, Inc. | 647.78M | 3.44% | 1,617,336 | - |
| 442 | ALLO | Allogene Therapeutics, Inc. | 638.54M | -4.15% | 5,342,280 | 22.00K |
| 443 | RGNX | REGENXBIO Inc. | 635.38M | -3.61% | 1,560,090 | 87.82M |
| 444 | TOI | The Oncology Institute, Inc. | 627.89M | 0.48% | 3,427,087 | 545.76M |
| 445 | PRME | Prime Medicine, Inc. | 626.74M | -1.28% | 3,485,555 | 4.03M |
| 446 | MDXG | MiMedx Group, Inc. | 625.57M | 2.94% | 1,405,319 | 389.42M |
| 447 | TCMD | Tactile Systems Technology, Inc. | 623.00M | -4.89% | 260,505 | 343.52M |
| 448 | CERS | Cerus Corporation | 615.13M | -0.65% | 1,884,963 | 216.56M |
| 449 | FDMT | 4D Molecular Therapeutics, Inc. | 611.63M | 3.54% | 636,952 | 88.24M |
| 450 | CTKB | Cytek Biosciences, Inc. | 596.64M | 2.44% | 976,708 | 204.17M |
| 451 | AGMB | AgomAb Therapeutics NV | 592.95M | -2.19% | 48,063 | - |
| 452 | WEAV | Weave Communications, Inc. | 591.17M | 2.06% | 1,404,941 | 248.72M |
| 453 | DNA | Ginkgo Bioworks Holdings, Inc. | 590.53M | -0.11% | 703,171 | 151.40M |
| 454 | BWAY | BrainsWay Ltd. | 582.31M | 2.48% | 67,758 | 56.22M |
| 455 | FLGT | Fulgent Genetics, Inc. | 581.08M | 0.20% | 248,420 | 320.35M |
| 456 | NVCT | Nuvectis Pharma, Inc. | 576.60M | -0.81% | 99,409 | - |
| 457 | MYGN | Myriad Genetics, Inc. | 570.47M | 3.07% | 884,468 | 829.00M |
| 458 | ALT | Altimmune, Inc. | 569.81M | -2.01% | 3,247,927 | 36.00K |
| 459 | EIKN | Eikon Therapeutics, Inc. | 551.67M | -2.39% | 269,461 | - |
| 460 | CTNM | Contineum Therapeutics, Inc. | 544.72M | -0.34% | 252,237 | - |
| 461 | ANGO | AngioDynamics, Inc. | 541.87M | 1.72% | 1,646,881 | 320.17M |
| 462 | NPCE | NeuroPace, Inc. | 540.04M | -7.48% | 183,620 | 99.53M |
| 463 | ARVN | Arvinas, Inc. | 533.59M | 2.10% | 622,029 | 89.40M |
| 464 | ASMB | Assembly Biosciences, Inc. | 530.31M | -0.74% | 103,385 | 71.10M |
| 465 | TLRY | Tilray Brands, Inc. | 522.46M | -1.79% | 3,379,785 | 858.28M |
| 466 | CBIO | Crescent Biopharma, Inc. | 508.57M | -2.45% | 76,916 | 11.88M |
| 467 | AQST | Aquestive Therapeutics, Inc. | 506.89M | -0.49% | 885,865 | 50.27M |
| 468 | RZLT | Rezolute, Inc. | 504.57M | 1.90% | 1,501,494 | - |
| 469 | MCTA | Charming Medical Limited | 504.26M | -0.85% | - | 5.42M |
| 470 | NRC | NRC Health | 495.36M | 0.69% | 95,723 | 138.64M |
| 471 | KIDS | OrthoPediatrics Corp. | 494.44M | -7.09% | 227,068 | 243.30M |
| 472 | VSTM | Verastem, Inc. | 489.46M | 3.72% | 2,956,753 | 49.59M |
| 473 | EDIT | Editas Medicine, Inc. | 484.94M | - | 1,816,150 | 38.69M |
| 474 | OCGN | Ocugen, Inc. | 484.09M | 1.42% | 4,932,152 | 4.47M |
| 475 | CTEV | Claritev Corporation | 483.48M | -4.96% | 218,354 | 978.76M |
| 476 | KYTX | Kyverna Therapeutics, Inc. | 482.71M | 2.19% | 1,306,134 | - |
| 477 | STTK | Shattuck Labs, Inc. | 482.32M | -2.18% | 738,258 | 1.00M |
| 478 | ZURA | Zura Bio Limited | 480.69M | -1.75% | 780,509 | - |
| 479 | SGMT | Sagimet Biosciences Inc. | 478.89M | 8.46% | 1,158,556 | - |
| 480 | VALN | Valneva SE | 478.73M | -2.85% | 56,743 | 180.25M |
| 481 | CLPT | ClearPoint Neuro, Inc. | 478.63M | -3.33% | 514,868 | 40.61M |
| 482 | SOPH | SOPHiA GENETICS SA | 476.53M | -0.70% | 115,934 | 81.18M |
| 483 | PROK | ProKidney Corp. | 468.19M | -3.73% | 1,770,211 | 889.00K |
| 484 | PACB | Pacific Biosciences of California, Inc. | 465.90M | 0.67% | 2,649,359 | 160.03M |
| 485 | SLN | Silence Therapeutics plc | 460.53M | 4.95% | 333,280 | 839.00K |
| 486 | OVID | Ovid Therapeutics Inc. | 459.13M | 1.23% | 1,225,605 | 7.12M |
| 487 | VMD | Viemed Healthcare, Inc. | 457.74M | -3.16% | 370,253 | 286.57M |
| 488 | SRTA | Strata Critical Medical, Inc. | 456.86M | 5.39% | 734,942 | 228.58M |
| 489 | ARTV | Artiva Biotherapeutics, Inc. | 454.30M | 4.70% | 415,557 | 251.00K |
| 490 | DCTH | Delcath Systems, Inc. | 453.61M | 2.10% | 280,632 | 90.44M |
| 491 | PRTA | Prothena Corporation plc | 452.33M | -2.15% | 522,031 | 57.94M |
| 492 | SI | Shoulder Innovations, Inc. | 447.74M | -3.53% | 79,276 | 53.89M |
| 493 | BNTC | Benitec Biopharma Inc. | 445.92M | -0.08% | 65,169 | - |
| 494 | VREX | Varex Imaging Corporation | 445.49M | -2.13% | 644,840 | 857.50M |
| 495 | OFIX | Orthofix Medical Inc. | 442.62M | -7.12% | 303,146 | 825.37M |
| 496 | PRLD | Prelude Therapeutics Incorporated | 435.39M | -1.13% | 322,446 | 16.72M |
| 497 | CABA | Cabaletta Bio, Inc. | 435.36M | -3.44% | 3,134,870 | - |
| 498 | CYH | Community Health Systems, Inc. | 432.10M | -8.33% | 3,218,807 | 12.29B |
| 499 | EVMN | Evommune, Inc. | 431.86M | -0.91% | 572,883 | 10.00M |
| 500 | STRO | Sutro Biopharma, Inc. | 431.33M | -6.50% | 217,687 | 99.61M |